Pfizer tests demand for Haleon shares with long-awaited £2bn selldown
US drug maker's stake in Haleon set to fall to 24%
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
Pfizer tests demand for Haleon shares with long-awaited £2bn selldown